Journal Information
Vol. 45. Issue 4.
Pages 181-185 (April 2009)
Share
Share
Download PDF
More article options
Vol. 45. Issue 4.
Pages 181-185 (April 2009)
Original article
Full text access
Causes of Death and Risk Factors for Mortality in Patients With Severe Chronic Obstructive Pulmonary Disease
Causas de muerte en pacientes con EPOC grave. Factores pronósticos
Visits
5204
Amalia Morenoa, Concepción Montóna,
Corresponding author
cmonton@tauli.cat

Corresponding author.
, Yolanda Belmontea, Miguel Gallegoa, Xavier Pomaresa, Jordi Realb
a Servicio de Neumología, Hospital de Sabadell, Corporació Parc Taulí, Sabadell, Barcelona, Spain
b Servicio de Epidemiología, Unitat de Suport a la Recerca (USR) Lleida, IDIAP Jordi Gol, Lleida, Spain
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics
Abstract
Objective

The objective of this study was to assess the causes of death and risk factors for mortality in a cohort of patients with severe chronic obstructive pulmonary disease (COPD).

Patients and methods

We studied 203 patients with severe COPD (forced expiratory volume in 1 second [FEV1] <50%), who were attended in our respiratory department day hospital (2001-2006). Clinical variables were recorded on inclusion, and clinical course and causes of death were retrospectively reviewed.

Results

The mean (SD) age of patients was 69 (8) years and the mean FEV1 was 30.8% (8.2%). One-hundred and nine patients died (53.7%); death was attributed to respiratory causes in 72 (80.9%), with COPD exacerbation being the most frequent specific cause within this category (48.3%). During follow-up, 18.7% required admission to the intensive care unit (ICU). Survival at 1, 3, and 5 years was 80%, 53%, and 26%, respectively. The multivariate analysis showed that mortality was associated with age, stage IV classification according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD), cor pulmonale, and hospital admission during the year prior to inclusion. Need for admission to the ICU during follow-up was a factor independently associated with higher mortality.

Conclusions

Mortality in patients with severe COPD was high and exacerbation of the disease was one of the most frequent causes of death. Age, GOLD stage, cor pulmonale, prior admission to hospital, and need for admission to the ICU during follow-up were independent predictors of mortality.

Keywords:
Chronic obstructive pulmonary disease
Mortality
Survival
Resumen
Objetivo

El objetivo del estudio es evaluar las causas de muerte y los factores pronósticos de mortalidad en una cohorte de pacientes con enfermedad pulmonar obstructiva crónica (EPOC) grave.

Pacientes y métodos

Se incluyó a 203 pacientes con EPOC grave (volumen espiratorio forzado en el primer segundo < 50%) controlados en el Hospital de Día de Neumología (2001-2006). Se registraron diversas variables clínicas en el momento de la inclusión, y se revisaron retrospectivamente la evolución y las causas de muerte.

Resultados

La edad media (± desviación estándar) de los pacientes fue de 69 ± 8 años, y el volumen espiratorio forzado en el primer segundo del 30,8 ± 8,2%. Fallecieron 109 pacientes (53,7%). De éstos, 72 murieron de causas respiratorias (80,9%), de las cuales la exacerbación de la EPOC fue la más frecuente (48,3%). Durante el seguimiento, el 18,7% precisó ingreso en la Unidad de Cuidados Intensivos (UCI). La supervivencia al año, a los 3 y 5 años fue del 80, el 53 y el 26%, respectivamente. El análisis multivariante mostró que la mortalidad se asociaba a la edad, al estadio IV de la clasificación de la Global Initiative for Chronic Obstructive Lung Disease (GOLD), al cor pulmonale y a la estancia hospitalaria durante el año previo a la inclusión. La necesidad de ingreso en la UCI durante el seguimiento constituyó un factor independiente asociado a mayor mortalidad.

Conclusiones

La mortalidad en la EPOC grave es elevada y la exacerbación de la enfermedad constituye la causa más frecuente. La edad, el estadio GOLD, el cor pulmonale, los ingresos hospitalarios previos y la necesidad de ingreso en la UCI durante el seguimiento son factores pronósticos independientes de mortalidad.

Palabras clave:
EPOC
Mortalidad
Supervivencia
Full text is only aviable in PDF
References
[1.]
World Health Organization.
World Health Report.
World Health Organization, (2000),
[2.]
D.D. Sin, N.R. Anthonisen, J.B. Soriano, A.G. Agustí.
Mortality in COPD: role of comorbidities.
Eur Respir J, 28 (2006), pp. 1245-1257
[3.]
S. Martí, X. Muñoz, J. Ríos, F. Morell, J. Ferrer.
Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy.
Eur Respir J, 27 (2006), pp. 689-696
[4.]
J.J. Soler-Cataluña, M.A. Martínez-García, P. Román Sánchez, E. Salcedo, M. Navarro, R. Ochando.
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.
Thorax, 60 (2005), pp. 925-931
[5.]
I. Solanes, P. Casan, M. Sangenís, N. Calaf, B. Giraldo, R. Güell.
Factores de riesgo de mortalidad en la EPOC.
Arch Bronconeumol, 43 (2007), pp. 445-449
[6.]
H. Gunen, S.S. Hacievliyagil, F. Kosar, L.C. Mutlu, G. Gulbas, E. Pehlivan, et al.
Factors affecting survival of hospitalised patients with COPD.
Eur Respir J, 26 (2005), pp. 234-241
[7.]
P. Almagro, E. Calbo, A. Ochoa de Echagüen, B. Barreiro, S. Quintana, J.L. Heredia, et al.
Mortality after hospitalization for COPD.
Chest, 121 (2002), pp. 1441-1448
[8.]
K.H. Groenewegen, A.M.W.J. Schols, E.F.M. Wouters.
Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD.
Chest, 124 (2003), pp. 459-467
[9.]
S. Iribarren-Diarasarri, F. Aizpuru-Barandiaran, A. Loma-Osorio, J. Castedo-González, Y. Poveda-Hernández, T. Muñoz-Martínez, et al.
Factores pronósticos de mortalidad en pacientes con enfermedad pulmonar obstructiva crónica tras su ingreso en una Unidad de Medicina Intensiva. El papel de la calidad de vida.
Medicina Intensiva, 29 (2005), pp. 204-211
[10.]
R. Rivera-Fernández, P. Navarrete-Navarro, E. Fernández-Mondéjar, M. Rodríguez-Elvira, F. Guerrero-López, G. Vázquez-Mata, Project for the Epidemiological Analysis of Critical Care Patients (PAEEC) Group.
Six-year mortality and quality of life in critically ill patients with chronic obstructive pulmonary disease.
Crit Care Med, 34 (2006), pp. 2317-2324
[11.]
Guía de práctica clínica de diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica. SEPAR-ALAT, 2007. Available from: www.separ.es.
[12.]
B.R. Celli, W. Macnee.
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.
Eur Respir J, 23 (2004), pp. 932-946
[13.]
S. Kesten, K.R. Chapman.
Physician perceptions and management of COPD.
Chest, 104 (1993), pp. 254-258
[14.]
K.F. Rabe, S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, P. Calverley, et al.
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. GOLD Executive Summary.
Am J Respir Crit Care Med, 176 (2007), pp. 532-555
[15.]
M. Charlson, T.P. Szatrowski, J. Peterson, J. Gold.
Validation of a combined comorbidity index.
J Clin Epidemiol, 47 (1994), pp. 1245-1251
[16.]
N.R. Anthonisen, M.A. Skeans, R.A. Wise, J. Manfreda, R.E. Kanner, J.E. Connett.
The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial.
Ann Intern Med, 142 (2005), pp. 233-239
[17.]
J. Zielinski, W. Macnee, J. Wedzicha, N. Ambrosino, A. Braghiroli, J. Dolensky, et al.
Causes of death in patients with COPD and chronic respiratory failure.
Monaldi Arch Chest Dis, 52 (1997), pp. 43-47
[18.]
J. García-Aymerich, E. Farrero, M.A. Félez, J. Izquierdo, R.M. Marrades, J.M. Antó.
Risk factors of readmission to hospital for a COPD exacerbation: a prospective study.
Thorax, 58 (2003), pp. 100-105
[19.]
N.R. Anthonisen, E.C. Wright, J.E. Hodgkin.
Prognosis in chronic obstructive pulmonary disease.
Am Rev Respir Dis, 133 (1986), pp. 14-20
[20.]
A. Domingo-Salvany, R. Lamarca, M. Ferrer, J. García-Aymerich, J. Alonso, M. Félez, et al.
Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 166 (2002), pp. 680-685
[21.]
R.A. Incalzi, L. Fuso, M. De Rosa, A. Di Napoli, S. Basso, G. Pagliari, et al.
Electrocardiographic signs of chronic cor pulmonale: a negative prognostic finding in chronic obstructive pulmonary disease.
Circulation, 99 (1999), pp. 1600-1605
[22.]
B.R. Celli, C.G. Cote, J.M. Marín, C. Casanova, M. Montes de Oca, R.A. Méndez, et al.
The body-mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease.
N Engl J Med, 350 (2004), pp. 1005-1012
[23.]
J. Vestbo, E. Prescott, T. Almdal, M. Dahl, B.G. Nordestgaard, T. Andersen, et al.
Bodymass, fat-free body mass and prognosis in patients with chronic pulmonary obstructive disease from a random population sample. Findings from the Copenhagen City Heart Study.
Am J Respir Crit Care Med, 173 (2006), pp. 79-83
[24.]
J.J. Soler Cataluña, M.A. Martínez García.
Factores pronósticos en la EPOC.
Arch Bronconeumol, 43 (2007), pp. 680-691
[25.]
C. Casanova, C. Cote, J.P. De Torres, A. Aguirre-Jaime, J.M. Marín, V. Pinto-Plata, et al.
Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 171 (2005), pp. 591-597
Copyright © 2009. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?